newsfilter
← Latest News
Business Wire·

Virpax Looking to Use MET to Develop Intranasal COVID Vaccine

Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX) ("Virpax" or the "Company"), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous system (CNS)